Skip to main content
NCBI home page
AAPS PharmSciTech logoLink to AAPS PharmSciTech
. 2007 Dec 28;8(4):281–288. doi: 10.1208/pt0804115

Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets

Eddy Castellanos Gil 1,2,3,✉, Antonio Iraizoz Colarte 2, Bernard Bataille 3, Isidoro Caraballo 4
PMCID: PMC2750701  PMID: 18181536

Abstract

The objective of the present work is to estimate for the first time the percolation threshold of a new series of dextran (native dextran of high molecular weight [B110-1-2, Mw=2×106]), in matrices of lobenzarit disodium (LBD) and to apply the obtained result to the design of hydrophilic matrices for the controlled delivery of this drug. The formulations studied were prepared with different amounts of excipient in the range of 20% to 70% wt/wt. Dissolution studies were performed using the paddle method (100 rpm) and one face water uptake measurements were performed using a modified Enslin apparatus. The Higuchi, zero-order, and Hixson-Crowell models as well as the nonlinear regression model were employed as empiric methods to study the release data. Values of diffusion exponent 0.563<n<0.786 (Korsmeyer equation) for dissolution profile and water uptake mechanism 0.715<n<1 (Davidson and Peppas equation) suggested anomalous or complex mechanisms. On the other hand, the contribution of the relaxation or erosion and of the diffusive mechanism in Peppas-Sahlin equation indicated that the main mechanism for drug delivery from tablets is swelling controlled delivery (Kr/Kd<1). The critical points observed in kinetic parameters above 58.63% vol/vol of native dextran B110-1-2 plus initial porosity in the LBD-dextran matrices with a relative polymer/drug particle size of 4.17 were attributed to the existence of an excipient percolation threshold.

Keywords: Dextran, lobenzarit, percolation, swelling, threshold

Full Text

The Full Text of this article is available as a PDF (378.0 KB).

References

  • 1.Coviello T, Matricardi P, Marianecci C, Alhaique F. Polysaccharide hydrogels for modified release formulations. J Control Release. 2007;119:5–24. doi: 10.1016/j.jconrel.2007.01.004. [DOI] [PubMed] [Google Scholar]
  • 2.Robyt JF. Dextran. In: Mark HF, Bikales NM, Overberger CG, Menges G, editors. Encyclopedia of Polymer Science and Engineering. New York, NY: John Wiley & Sons; 1986. pp. 752–767. [Google Scholar]
  • 3.Gil EC, Colarte AI, El Ghzaoui A, Durand D, Delarbre JL, Bataille B. A sugar cane native dextran as an innovative functional excipient for the development of pharmaceutical tablets.Eur J Pharm Biopharm. In press. [DOI] [PubMed]
  • 4.Ferrero C, Muñoz-Ruiz A, Jiménez-Castellanos MR. Fronts movements as a useful tool for hydrophilic matrix release mechanism elucidation. Int J Pharm. 2000;202:21–28. doi: 10.1016/S0378-5173(00)00407-5. [DOI] [PubMed] [Google Scholar]
  • 5.Tahara K, Yamamato K, Nishihata T. Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methylcellulose 2910. J Control Release. 1995;35:59–66. doi: 10.1016/0168-3659(95)00021-Y. [DOI] [Google Scholar]
  • 6.Jamzad S, Tutunji L, Fassihi R. Analysis of macromolecular changes and drug release from hydrophilic matrix systems. Int J Pharm. 2005;292:75–85. doi: 10.1016/j.ijpharm.2004.11.011. [DOI] [PubMed] [Google Scholar]
  • 7.Gil EC, Colarte AI, Bataille B, Pedráz JL, Heinämäki J. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride. Int J Pharm. 2006;317:32–39. doi: 10.1016/j.ijpharm.2006.02.049. [DOI] [PubMed] [Google Scholar]
  • 8.Campos-Aldrete ME, Villafuerte-Robles L. Influence of the viscosity grade and the particle size of HPMC on metronidazole release from matrix tablet. Eur J Pharm Biopharm. 1997;43:173–178. doi: 10.1016/S0939-6411(96)00004-5. [DOI] [Google Scholar]
  • 9.Miranda A, Millán M, Caraballo I. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery. Int J Pharm. 2006;311:75–81. doi: 10.1016/j.ijpharm.2005.12.012. [DOI] [PubMed] [Google Scholar]
  • 10.Miranda A, Millán M, Caraballo I. Study of the critical points in lobenzarit disodium hydrophilic matrices for controlled drug delivery. Chem Pharm Bull (Tokyo) 2006;54:598–602. doi: 10.1248/cpb.54.598. [DOI] [PubMed] [Google Scholar]
  • 11.Fuertes I, Miranda A, Millian M, Caraballo I. Estimation of percolation thresholds in acyclovir hydrophilic matrix tablets. Eur J Pharm Biopharm. 2006;64:336–342. doi: 10.1016/j.ejpb.2006.05.009. [DOI] [PubMed] [Google Scholar]
  • 12.Leuenberger H, Rohera BH, Haas C. Percolation theory—a novel approach to solid dosage form design. Int J Pharm. 1987;38:109–115. doi: 10.1016/0378-5173(87)90105-0. [DOI] [Google Scholar]
  • 13.Caraballo I, Fernandez Arévalo M, Millán M, Rabasco AM, Leuenberger H. Study of percolation thresholds in temary tablets. Int J Pharm. 1996;139:177–186. doi: 10.1016/0378-5173(96)04603-0. [DOI] [Google Scholar]
  • 14.Stauffer D, Aharony A. Introduction to Percolation Theory. Washington, DC: Francis; 1992. [Google Scholar]
  • 15.Zallen R. Percolation: a model for all seasons. In: Deutscher G, Zallen R, Adler J, editors. Percolation Structures and Processes. New York NY: The American Institute of Physics; 1983. [Google Scholar]
  • 16.Ohsugi Y, Nakano T, Ueno K. An immunopharmacological profile of lobenzarit disodium (CCA), a new immunomodulatory anti-rheumatic drug. Int J Immunother. 1985;2:85–92. [Google Scholar]
  • 17.Castellanos GE, Caraballo I, Bataille B. Tablet design. In: Gad SC, ed.Pharmaceutical Manufacturing Handbook. Hoboken, NJ: John Wiley & Sons; In press.
  • 18.Novoa H, Pellón R, Pomés P, Duque J. Crystal data and x-ray powder diffraction data of lobenzarit acid and lobenzarit disodium. Powder Diffraction. 1996;11:72–74. [Google Scholar]
  • 19.Ritger PL, Peppas NA. A simple equation for description of solute release. I. Fickian and Non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 1987;5:23–36. doi: 10.1016/0168-3659(87)90034-4. [DOI] [PubMed] [Google Scholar]
  • 20.Davidson GWR, Peppas NA. Relaxation-controlled transport in P(HEMA-co-MMA) copolymers. J Control Release. 1986;3:243–258. doi: 10.1016/0168-3659(86)90096-9. [DOI] [Google Scholar]
  • 21.Lin CC, Metters AT. Hydrogels in controlled release formulations: network design and mathematical modelling. Adv Drug Deliv Rev. 2006;58:1379–1408. doi: 10.1016/j.addr.2006.09.004. [DOI] [PubMed] [Google Scholar]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES